Nanophase reports record Q2 2022 revenue of $11.2M, up 58% YoY; Solésence revenue up 58%

SOLESENCE, INC.

2022-Q2 EPS reported $0.00 revenue$19,378,000

Q2 revenue $11.2M, a record, up 58% from $7.1M in Q2 2021.
Solésence revenue $7.1M (+58% YoY); Personal Care Ingredients $3.3M (+86% YoY).
Six-month revenue $19.4M, up 37% from $14.2M in prior year.
Over 40 new products shipped and 20 new brand partners added in Q2.
June 2022 was highest monthly revenue in company history at ~$4.9M.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.